EP News Bureau

Event organised by Informa Markets in India to bring over 2,000 exhibitors and 50,000 industry participants from more than 120…

The initiative aims to expand preventive education, screenings, and community engagement across 450 districts in India

The deal adds multiple clinical-stage candidates, including GLP-1 and amylin assets, as Metsera becomes a wholly owned Pfizer…

The P80x features MOF-based MIRACLE Next-Gen Rotor and heat pump compatibility for reduced energy use and lower regeneration…

The launch marks Lupin’s first product using PrecisionSphereTM, the long-acting injectable platform developed by Nanomi B.V.

The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…

Alembic Pharmaceuticals secures final USFDA approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg,…

Lupin reports a 91-point S&P Global ESG Score for 2025, exceeding the pharma industry average of 28 and marking a major rise…

The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…

The initiative focuses on building India’s capacity in CAR-T cell therapy through practical training and industry-academia…